[go: up one dir, main page]

NO20041633L - Fremgangsmate for fremstilling av heparin fra mastcelle kulturer - Google Patents

Fremgangsmate for fremstilling av heparin fra mastcelle kulturer

Info

Publication number
NO20041633L
NO20041633L NO20041633A NO20041633A NO20041633L NO 20041633 L NO20041633 L NO 20041633L NO 20041633 A NO20041633 A NO 20041633A NO 20041633 A NO20041633 A NO 20041633A NO 20041633 L NO20041633 L NO 20041633L
Authority
NO
Norway
Prior art keywords
heparin
preparation
cell cultures
mast cell
mast
Prior art date
Application number
NO20041633A
Other languages
English (en)
Norwegian (no)
Inventor
Jean-Marc Guillaume
Pierrre Cans
Helene Monique Marie Rigal
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20041633L publication Critical patent/NO20041633L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20041633A 2001-10-22 2004-04-21 Fremgangsmate for fremstilling av heparin fra mastcelle kulturer NO20041633L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113606A FR2831186B1 (fr) 2001-10-22 2001-10-22 Production d'heparine a partir de cultures de mastocytes
PCT/FR2002/003617 WO2003035886A2 (fr) 2001-10-22 2002-10-22 Preparation d'heparine a partir de cultures de mastocytes

Publications (1)

Publication Number Publication Date
NO20041633L true NO20041633L (no) 2004-04-21

Family

ID=8868558

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041633A NO20041633L (no) 2001-10-22 2004-04-21 Fremgangsmate for fremstilling av heparin fra mastcelle kulturer

Country Status (18)

Country Link
US (1) US20050042733A1 (es)
EP (1) EP1438415A2 (es)
JP (1) JP2005506092A (es)
KR (1) KR20040071127A (es)
CN (1) CN1575341A (es)
AR (1) AR036915A1 (es)
BR (1) BR0213478A (es)
CA (1) CA2462714A1 (es)
CO (1) CO5570711A2 (es)
FR (1) FR2831186B1 (es)
HU (1) HUP0401794A2 (es)
IL (1) IL161066A0 (es)
MX (1) MXPA04003740A (es)
NO (1) NO20041633L (es)
NZ (1) NZ532414A (es)
PL (1) PL368599A1 (es)
WO (1) WO2003035886A2 (es)
ZA (1) ZA200402304B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2853663B1 (fr) * 2003-04-14 2007-08-31 Aventis Pharma Sa Procede d'obtention de lignees de mastocytes a partir de tissus de porcs et procede de production de molecules de type heparine
FR2876386B1 (fr) * 2004-10-12 2007-04-06 Aventis Pharma Sa Lignees de mastocytes porcins produisant des molecules de type heparine
KR100688553B1 (ko) * 2005-06-22 2007-03-02 삼성전자주식회사 코어 사이즈를 감소시킨 반도체 메모리 장치
KR101447123B1 (ko) * 2014-02-27 2014-10-06 박상협 헤파린의 추출 방법
KR102104367B1 (ko) 2019-09-02 2020-04-24 팜앤바이오 주식회사 헤파린나트륨의 제조장치 및 제조방법
CN111979193A (zh) * 2019-09-27 2020-11-24 云南洛宇生物科技有限公司 大鼠骨髓源肥大细胞培养方法
CN110592165B (zh) * 2019-10-18 2021-04-27 福州大学 燕窝中硫酸乙酰肝素/肝素的提取方法与结构解析

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016331A (en) * 1960-01-28 1962-01-09 Ormonoterapia Richter Spa Purification of heparin
WO1990014418A1 (en) * 1989-05-19 1990-11-29 The Uab Research Foundation Heparin-producing murine mastocytoma cell lines
ES2108566T3 (es) * 1993-12-10 1997-12-16 Genentech Inc Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos.
FI974321A0 (fi) * 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
US6596705B1 (en) * 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin

Also Published As

Publication number Publication date
AR036915A1 (es) 2004-10-13
BR0213478A (pt) 2004-11-03
FR2831186B1 (fr) 2004-06-18
CO5570711A2 (es) 2005-10-31
US20050042733A1 (en) 2005-02-24
IL161066A0 (en) 2004-08-31
JP2005506092A (ja) 2005-03-03
WO2003035886A2 (fr) 2003-05-01
HUP0401794A2 (hu) 2004-11-29
NZ532414A (en) 2006-12-22
CN1575341A (zh) 2005-02-02
FR2831186A1 (fr) 2003-04-25
EP1438415A2 (fr) 2004-07-21
KR20040071127A (ko) 2004-08-11
CA2462714A1 (fr) 2003-05-01
WO2003035886A3 (fr) 2004-02-26
PL368599A1 (en) 2005-04-04
MXPA04003740A (es) 2005-06-20
ZA200402304B (en) 2004-10-07

Similar Documents

Publication Publication Date Title
NO20042159L (no) Cellokulturprosess
DK1360287T4 (da) Fremgangsmåder til modifikation af eukaryotiske celler
IL146389A0 (en) Process for the preparation of dronedarone
HUP0402415A3 (en) Method for large scale production of virus antigen
DK1240104T3 (da) Kontinuerlig produktion af silika-baserede mikrogeler
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
HUP0500161A3 (en) Methods to culture circovirus
IL157304A0 (en) Method of extracting virus from cell culture
FI20011621A0 (fi) Menetelmä sitalopraamin valmistamiseksi
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
EE200300442A (et) Meetod imidasoolühendite valmistamiseks
NO20041633L (no) Fremgangsmate for fremstilling av heparin fra mastcelle kulturer
DE602004023786D1 (de) Herstellung von hochreinem Alkylgallium
NO20035633D0 (no) Teknisk syntesemetode for fremstilling av tropenol
FI20010706L (fi) Menetelmä perkarboksyylihapon valmistamiseksi
ITMI20000026A0 (it) Procedimento per la produzione di gas di sintesi
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
PL354948A1 (en) Novel benzenesulphonamide compounds, method of obtaining them and pharmacological compositions containing such compounds
NO20033819L (no) Fremgangsmåte ved regulering av elektrolysecelle
ITMI20020782A0 (it) Processo semisintetico per la preparazione di n-debenzoilpaclitaxel
DK1438286T3 (da) Fremgangsmåde til fremstilling af arylsulfonsyreisocyanater
NO20043935L (no) Fremgangsmåte ved fremstilling av interferon
NO20033840D0 (no) Fremgangsmåte for fremstilling av mirtazapinmellomprodukter
AU2002358848B2 (en) Method for preparing heparin from mast cell cultures

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application